Merck’s lead internal ADC candidate M9140 is currently in Phase I trials for colorectal cancer. Merck expects the SpringWorks ...

RAHWAY, N.J. - Merck & Co., Inc., known as MSD outside the United States and Canada, has reached a pivotal milestone with its ...